Method of producing catechine derivatives

专利摘要:
A catechol derivative represented by the formula wherein R' represents a hydrogen atom or a C, to C5 alkyl group; R2 represents a hydrogen atom or a halogen atom; X represents a straight chain or branched alkylene group having 1 to 15 carbon atoms or a vinylene group; Y represents a carbonyl group or a group represented by represents a hydrogen atom or a C, to C. alkyl group) and Z represents a hydrogen atom, a straight chain or branched alkyl group having 1 to 15 carbon atoms ora cycloalkyl group; the sum of the carbon atoms of said X and Z being at least 3. The compounds of this invention are useful for the prophylaxis and treatment for various allergic diseases, ischemic heart diseases an inflammations caused by slow reacting substance of anaphylaxis (SRS-A), since the compounds inhibit very potently the formation and release of SRS-A.
公开号:SU1424729A3
申请号:SU843743757
申请日:1984-05-11
公开日:1988-09-15
发明作者:Мурасе Киеси；Масе Тосиясу；Арима Хидеки；Томиока Кенити
申请人:Яманоути Фармасьютикал Ко,Лтд (Фирма)；
IPC主号:

专利说明:

This invention relates to a process for the preparation of catechin derivatives of general formula I
HE
.he
X-y-z
X is an alkylene of normal structure, containing 1-11 carbon atoms, or a vinylene group;
Y is a carbonyl or C (OR,) R2 radical, where R and R are the same or different and are hydrogen or lower alkyl;
Z is hydrogen, normal alkyl or isotole containing 1-12 carbon atoms, the sum of carbon atoms in X and Y radicals being at least 3, new ones are new compounds
20 under reduced pressure to obtain a solid product, washing it with a mixture of ether and hexane (1: 3) to obtain 0.4 g of 1- (3,4-benzyloxyphenyl-4-methyl-oct-1-ene-3 a-la
and can be used to obtain, j, 77-78 ° C
According to reference examples 1a and 16, compounds of reference examples 2a and 26 were prepared, and compounds of reference examples 3-7 were prepared by the method of reference example 1a.
Reference Example 2a (original compound used in example 3).
medical preparations or for the preparation of intermediates for such preparations.
The purpose of the invention is a method of obtaining new catechin derivatives having increased antihistamine activity.
The invention is illustrated by the following examples.
thirty
, 1- (3,4-Dibenzyloxyphenyl) non-1-en-3-one, m.p. 78-80 C.
Since the starting compounds used in the following examples are new compounds, methods for preparing such compounds are explained by the following reference examples.
Session Example 1a. When taking a mixture of 400 mg of sodium hydride in oil (60%) and 50 mp of 1,2-dimethoxymethane, a solution of 2.36 dimethyl- (3-methyl-2) is added dropwise to it at 20-25 ° C. -oxoheptyl) phosphonate in 5 mp dimethoxyethane. After the resulting mixture was stirred for 2 hours at room temperature, the reaction mixture was cooled to 5-7 ° C and a solution of 2.3 g of 3,4-dibenzyl-hydroxybenzaldehyde in 5 mp of dimethoxyethylene was added dropwise.
After stirring the reaction mixture for 2 hours at room temperature, 300 ml of water is added to it, which is extracted with a mixture of toluene-n-hexane (1: 1, 50 ml). The extract is washed with water, dried over anhydrous magnesium sulphate and concentrated under reduced pressure to give a sticky residue, which is applied to silica gel (70 ml) for column chromatography and eluted with a mixture of N-hexane and zfir (4: 1) obtaining 1.2 g of 1- (3,4-dibenzyloxyphenyl) -4-methyloxy-1-one-3-one, m.p. 62-64 ° C. Reference Example 16. To a mixture, obtained by adding O, 1 g of lithium aluminum hydride to 20 ml of ether, 0.55 g of 1- (3, 4-benzyloxyphenyl) oct-1-en-3-one the mixture was stirred for 1 h at room temperature. The reaction mixture is gradually poured into 10 ml of an aqueous solution of hydrochloric acid, the ether layer is separated, washed with water and concentrated under reduced pressure to obtain a solid product, which is obtained with a mixture of ether and hexane (1: 3) to obtain 0.4 g 1 - (3,4-benzyl-oxyphenyl-4-methyl-oct-1-en-3-ol.
, j, 77-78 С
Reference Example 2a (source compound used in example 3)
, 1- (3,4-Dibenzyloxyphenyl) non-1-en 3-one, m.p. 78-80 C.
Calculated,%: C 81.27; H 7.53. Cj, H ,.
Found,%: C 81.21; H 7.65. Reference Example 2b "(starting compound used in Example 2).
Based on the compound synthesized in step a, 1- (3,4-dibenzyloxyphenyl) non-1-ene-3-ol was obtained. M.p. 90-92 S.
Reference example 3 (the original compound used in example 4).
1- (3,4-Dibenzyloxyphenyl) pentaden 1 en-3-one, m.p. 81-82 C.
Calculated,%: C, 81.99; H 8.65.
C, 5,
Found,%: C 81.78; H 8.81.
Reference Example 4 (the starting compound used in Example 5).
1- (3,4-Dibenzyloxyfennet) -4-ethyl-oct-1-ene-3-one, oily product.
Nuclear Magnetic Resonance Spectrum (in CdClj, internal standard TMS, ppm): 0.86 (6H); 1.1-1.9 (8H); 2.65 (1H); 5.15 (4H); 6.4-7.6 (15H).
Reference example 5 (source connection used in example 6),
1- (3,4-Dibenzyloxyfet1l) hex-1-en-g3-one, m.p. 82-84 s. , Zr and isleno,%: C 8.80; H 6.78.
C Oe
Found,%: C 8.80; H 6.81.
Reference example 6 (the original compound used in example 7).
1- (3,4-Dibenzyloxyfensch1) oct-1-en 3-one, m.p. 71-73 S.
Calculated,%: C 81.13; H 7.29.
Found,%: C 80.91; H 7.47.
Reference Example 7 (original compound used in Example 8),
1- (3,4-Dibenzyloxyphenyl) -dec-1-en-3-one, m.p. 73-75 C.
Calculated,%: C 81.41; H 7.74.
,, 0,
Found,%: C, 81.26; H 7.97.
In addition, the following lists the properties and methods for preparing the dimethyl esters of 2-oxoalkylphosphonic acids used in the reference examples.
Method A. In 65 MP of anhydrous tetrahydrofuran, 12.75 g of methyl methyl phosphoric acid methyl ester is dissolved and the resulting solution is cooled below -70 ° C. Then, with stirring
in a stream of nitrogen add it
i-n c and c
five
thief butyl lithium (Bull) in hexane (10 v / may) drop by drop for 30 minutes and the resulting mixture is stirred at -70 ° C for 15 minutes, then a solution of 5.8 g of ethyl ester of 15 MP anhydrous tetra is added. - gi ;; rofurana, the mixture is stirred at a temperature below 1.5 h and for another 2 h at room temperature.
The resulting reaction mixture is cooled with ice, mixed with 10 ml of glacial acetic acid, dissolved:; distilled out of the mixture under reduced pressure. 50 ml of water are added to the residue, after which they are extracted three times. ovoid ether, 50 ml each time. The extracts are combined, twice washed with 20 ml of a saturated solution of sodium chloride. After drying the extract over anhydrous sulfate M..I
No, the solvent is distilled off when it is understood.
and the residue is distilled in vacuo to give 9.7 g of 2-oxo-1-methylphosphonic acid dimethyl ester, b.p. 95-97 C / / 0.9 mm Hg.
Following the method of the method L, Q phosphonates obtained the following peak with the following so kip .:
0
five
(CHjO) iP (0) CHjC (0) (CH) 4CH, (CH, 0) j P (O) CHjC (O) (Sig) "SI, () jP (0) CHiC (0) CH (CH, CH,) (CH), SI (CH, 0) P (0) SI2C (0) C (CH,) (Clli), CH, (CHjO) jP (0) (0) (CH,), CH,
Method B. To a solution of 2.5 g of methylphosphonic acid dimethyl ester in 15 MP of anhydrous tetrahydrofuran, cooled below -70 ° C, 18.5 ml of a solution of butyl lithium in hexane (10 v / may) cooled to a lower temperature are added dropwise 70 ° C, the mixture is stirred in a stream of nitrogen for 30 minutes and another 15 minutes at the same temperature. A solution of tridecanoic acid ethyl ester (2.4 g) in 5 MP anhydrous tetrahydrofuran is then added dropwise over 10 minutes and the resulting mixture stirred for 1 h at a temperature below -70 ° C and another 2 h at room temperature.
The resulting reaction mixture is cooled with ice, mixed with 2 ml of glacial acetic acid, concentrated under reduced pressure, after which
113-115 ° С / 0.8 mm Hg 129-132 ° С / 0.9 mm Hg 126-128 С / 0.85 MMHg 104-108 s / a, 25 TOiHg 120-123 ° С / 0.4 mm Hg
extracted three times with ethyl ether each time 10 MP. The extracts were combined, washed with complete sodium chloride solution, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give an oily product that was applied to silica gel (40 gyy) for column chromatography and eluted with ethyl ether to give 2.5% g of dimethyl ester of 2-oxotride-canoylphosphonic acid, m.p., 37-38 ° C.
Reference Example 8 (the initial substance used in Example 13).
After the gradual addition of 0.5 g of 3,4-dibenzyloxy feschschet. |: Guide to 10 mg of an ethereal solution of n-tylmagnesium bromide prepared from 0.12 g of magnesium and 0.97 g of n-octyl bromide
yes, the mixture was stirred for 30 minutes at room temperature, 10 ml of a 5% aqueous hydrochloric acid solution was added to the resulting reaction mixture, and after stirring, the ether layer was separated. The ether solution is washed with water, dried with anhydrous magnesium sulfate and concentrated under reduced pressure to obtain 0.5 g of 1-3,4-dibenzyloxyphenyl decan-2-ol, m.p., 3-C 3 s (n-hexane).
Calculated,%: C 80.54; H 8.78.
From go
Found,%: C 80.68; H 8.58.
Following the procedure of Reference Example 8, compounds of Reference Examples 9-11 were obtained, the names of their melting points and / or nuclear magnetic resonance spectra (in CDClI, internal TMS standard, ppm) are given below.
Reference Example 9 (starting material used in Example 16).
1- (3,4-Dibenzyloxyfesh1l) nonan-2-ol.
NMR: 0.7-1.6 (15H); 2.57 (2H); 3.63 (1H); 5.08 (4H); 6.5-7 (1H).
Referential example 10. (the original substance used in example 17).
1- (3,4-Dibenzyloxyphenyl) undecan-2-ol, etc. 55-37 C.
NMR: 0.7-1.6 (19H); 2.57 (2H); 3.59 (1H); 5.07 (4H); 6.5-7.5 (13H).
Calculated,%: C 80.83; H 8.75.
C J, H
0.8 g of 1- (3,4-dibenzyloxy-fensh1) undecan-2-one is obtained, m.p. 68 ° C. Calculated,%: C 81.18; H 8.35.
ten
15
20
Found,%: C 80.83; H 8.89.
Reference example 11 (starting material used in example 18).
2- (3,4-Dibenzyloxyphenyl) -1 -cyclohexylethan-1-ol, m.p. 73-75 C.
Calculated,%: C, 80.73; H 7.74.
CjgHj O,
 ,
Found,%: C 81.13; H 8.28.
Reference example 13 (starting material used in example 15).
To a solution prepared by adding 200 mg of sodium hydride in oil (60%) to a mixture of 25 ml of 1,2-dimethyl tannol and 10 ml of dimethyl sulfoxide, is added dropwise a mixture of 1.2 g of 2-oxooctyl sulfonic acid dimethyl ester and 3 ml of dimethoxymethane and after adding small pieces of ice to it, the mixture is stirred for another 5–5 minutes. 200 ml of water are then added to the reaction mixture and extracted with toluene. The residue was subjected to silica gel column chromatography using toluene / ethyl acetate (10: 1) as an eluent to obtain 0.5 g of 1- (3,4-dibenzyloxyphenyl) dec-2-en-4-one. Nuclear Magnetic Resonance Spectrum (in CDClI, internal TMS standard, ppm): 0.7-1.8 (1H); 2.42 (2H); 3.24 (2H); 5.09 (4H); 6-7.7 (15H).
Reference Example 14 (starting material used in Example 19).
Using the procedure of Reference Example 13, 1- (3,4-dibenzyloxyphenyl) dec-3-en-5-one is obtained from 1- (3,4-dibenzyloxyphenyl) propioaldehyde and 35 dimethyl 2-oxohexylphosphonic O
New acid, so pl. 38-3.9 C.
Calculated,%: C 81.41; H 7.74.
25
thirty
Szd N ,, Oh,
Found,%: C 81.48; H 7.66.
Reference example 15 (starting material used in example 20).
15a. A mixture of 2 g of sodium hydride in oil (60%) and 90 ml of dimethyl sulfoxide ne |) is stirred for 1 hour at 55-60 ° C, then cooled to room temperature. Then a solution of 11 g of (4-carboxybutyl) triphenylphosphonium bromide in 25 ml of dimethyl was found,%, C, 80.65; H 7.8.
Reference Example 12 (starting material used in Example 14).
To a mixture of 15 ml of methylene chloride and 1.2 ml of pyridine is gradually added 2 g of chromic anhydride at a temperature of (0) - (- 5) ° C. Ra-50 sulfoxide is added to it, stirred at a room of 0.9 g 3 , 4-dibenzyloxyphenyldehyde at a temperature of 30 minutes, then to can-2-ol in 3 ml of methylene chloride. After stirring the mixture, a solution of 8 g of 3,4-diben-0-1 solution of 8 g of dropwise is added dropwise to the mixture for 20 minutes. The upper layer of the solution of chlorisyloxybenzaldehyde in 30 ml of dimethyl methylene is concentrated under reduced sulfoxide. The mixture is continued under intermittent pressure. The residue is subjected to sewing for 1 h at room column chromatography on silica gel with toluene as eluent and
temperature, then add 5 g of dry ice, then 250 ml of water and 30 ml
14247296
0.8 g of 1- (3,4-dibenzyloxy-fensh1) undecan-2-one is obtained, m.p. 68 ° C. Calculated,%: C 81.18; H 8.35.
five
0
 ,
Found,%: C 81.13; H 8.28.
Reference example 13 (starting material used in example 15).
To a solution prepared by adding 200 mg of sodium hydride in oil (60%) to a mixture of 25 ml of 1,2-dimethyl tannol and 10 ml of dimethyl sulfoxide, is added dropwise a mixture of 1.2 g of 2-oxooctyl sulfonic acid dimethyl ester and 3 ml of dimethoxymethane and after adding small pieces of ice to it, the mixture is stirred for another 5–5 minutes. 200 ml of water are then added to the reaction mixture and extracted with toluene. The residue was subjected to silica gel column chromatography using toluene / ethyl acetate (10: 1) as an eluent to obtain 0.5 g of 1- (3,4-dibenzyloxyphenyl) dec-2-en-4-one. Nuclear Magnetic Resonance Spectrum (in CDClI, internal TMS standard, ppm): 0.7-1.8 (1H); 2.42 (2H); 3.24 (2H); 5.09 (4H); 6-7.7 (15H).
Reference Example 14 (starting material used in Example 19).
Using the procedure of Reference Example 13, 1- (3,4-dibenzyl-oxyphenyl) dec-3-en-5-one is obtained from 1- (3,4-dibenzyloxyphenyl) -propioaldehyde and 5 dimethyl 2-oxohexylphospho O
New acid, so pl. 38-3.9 C.
Calculated,%: C 81.41; H 7.74.
five
0
Szd N ,, Oh,
Found,%: C 81.48; H 7.66.
Reference example 15 (starting material used in example 20).
15a. A mixture of 2 g of sodium hydride in oil (60%) and 90 ml of dimethyl sulfoxide ne |) is stirred for 1 hour at 55-60 ° C, then cooled to room temperature. Then a solution of 11 g of (4-carboxybutyl) triphenylphosphonium bromide in 25 ml of dimethyl sulfoxide is added dropwise to the mixture at room temperature, stirred at room temperature for 30 minutes, and then added to the resulting reaction mixture a solution of 8 g of 3,4-dibenzyloxybenzaldehyde in 30 ml of dimethyl sulfoxide. The mixture is stirred for 1 hour at room temperature.
sulfoxide, stirred at room temperature for 30 minutes, after which a solution of 8 g of 3,4-dibenzyloxybenzaldehyde in 30 ml of dimethyl sulfoxide is added dropwise to the resulting reaction mixture. The mixture is stirred for 1 hour at room temperature.
temperature, then add 5 g of dry ice, then 250 ml of water and 30 ml
10% aqueous hydrochloric acid solution and extracted with 300 ml of ether. The extract obtained is washed with water, dried over anhydrous magnesium sulphate and concentrated under reduced pressure to obtain a sticky product, which is subjected to silica gel column chromatography (150 ml) using H-hexane and ether (1: 1) as eluant to give 8.5 g 6- (3,4-dibenzyloxyfekyl) - hex-5-enoic acid. The product is dissolved in 30 ml of ethanol and catalytically hydrogenated using 1 g of 10% palladium on carbon as a catalyst until the uptake of hydrogen ceases. The catalyst is then removed by filtration, and the filtrate is concentrated under reduced pressure to obtain 3.8 g of 6- (3,4-dibenz1-oxyphenyl) hexanoic acid, m.p. 109 C.
156. A mixture of 3.8 g of 6- (3,4-dihydroxyphenyl) hexanoic acid, 8.6 g of benzyl chloride, 9.4 g of potassium carbonate, O, 1 g of tetra-n-butylammonium bromide and 50 MP H , N-dimethylformamide is stirred for 1 day at room temperature, nocrfe completion
reactions to the reaction mixture are added. ,, dibenzyloxyphenyl) hexyl, 0.12 g
200 ml of water and extracted three times with acetylacetone, 0.15 g of carbonate with caeffre 100 ml each time. Extraction, 0.02 g of sodium iodide and 5 ml
You are combined, washed with water, and the ethanol is boiled for 20 hours. Then, 15 ml of water are added to the reaction and dried over anhydrous sulfate-ammonium mixture.
magic and concentrated under reduced pressure to obtain a sticky product, which is subjected to silica gel column chromatography (150 ml) using a mixture of toluene and ethyl acetate (19: 1) in the eluent to obtain 3.4 g of 6- (3,4-dibene - zyloxyphenyl) hexanoic acid in the form of its benzyl ester.
The resulting ester was dissolved in 20 ml of ether and the resulting solution was added dropwise to a mixture of 0.5 g of lithium aluminum hydride and 50 ml of ether while cooling with ice. Then the reactionary. the mixture is stirred for 1 hour at room temperature and 30 ml of a 10% aqueous solution of hydrochloric acid are added while chilling with ice. The resulting organic layer is separated, washed with water, dried over anhydrous magnesium sulphate and concentrated at
reduced pressure to obtain lip- 55 5 ml of K, H-dimethylformamide and 500 ml of a product that is subjected to methyl iodide with stirring silica gel column chromatography (100 ml) using ice-cooling as an example. After stirring the mixture for 1 day at room temperature.
five
0
five
eluent a mixture of toluene with ethyl, p1i tate (4: 1) and paput 1.95 g of 6- (3,4-dibenzyloxyphenyl) ge.xanol.
The product is dissolved in 10 ml of methylene chloride and the resulting solution is added dropwise at room temperature to a solution of triphenylphosphine dibromide (prepared from 1.57 g of triphenylphosphine and 0.88 g of bromine) in methylene chloride, which also contains 0.45 g pyridine. The mixture is then stirred for 1 day at room temperature, the resulting reaction mixture is diluted with dilute hydrochloric acid, dried with water over anhydrous magnesium sulphate, concentrated under reduced pressure, the residue is subjected to 1; night chromatography on silica gel (jO mgO using as eluant mixtures of n-hexane with toluene (2: 1) and obtain 1.08 g of 6- (3,4-dibenz1shoxy-phenyl) hexnlbromide.
NMR spectrum (in CDCl ,, internal standard TMS ppm): 1.0-2.0 (8H); 2.50 (2H); 3.38 (2H); 5.13 (2H); 5.16 (2H); 6.6-6.92 (311); 7.1-7.5 (un). 15th century A mixture of 0.5 g of methyl 6- (3.4
extracted with 20 ml of ether. The extract is washed with water, dried over anhydrous magnesium sulphate, concentrated under reduced pressure to obtain a sticky product, which is subjected to column chromatography on silica gel (45 ml) using a mixture of toluene and ethyl acetate (30: 1) as eluent and get 33 mg 9- (3,4-dibenzyloxyphenyl) -non-2-one in the form of oil.
Nuclear Magnetic Resonance Spectrum (in CdCl ,, internal standard TMS, ppm): 1-2 (YUN); 2.1 (3N); 2.2-2.7 (4H); 3.08 (2H); 3.1 (2H) ;; 6.5-7 (ЗН); 7.2-7.6 (un).
Reference Example 16. To a mixture of 130 mg of sodium hydride in oil (60%) and 15 ml of H, H-dimethylformamide, a solution of 1.27 g of 1- (3,4-dibenzyloxyfere {osh) -4-methyloctane is added dropwise in succession 1-en-W-one (see reference example 1) in
5 ml of K, N-dimethylformamide and 500 ml of methyl iodide with stirring
and ice cooling. After stirring the mixture for 1 day at com)
npt11 (150 ml of T1 floor is leached to it; the resulting extract is extracted with ethyl acetate. Extract npoMi.maioT with water, dried over anhydrous magnesium sulfate, concentrated under reduced pressure to obtain a sticky product, which is subjected to column chromatography on silica gel (0 d) using a mixture of n-hexane and ether (4: 1) as eluent, and 970 g of 1- (3, A-dibenzyloxyphenyl) -3-methoxy-D-methyloct-1-ene are obtained, m.p. 36-38 C.
Reference example 17 (starting material used in example 23).
17a. In 20 MP of xylene, 35 g of decanediol is dissolved by heating and after adding 1.65 g of sodium metal to the solution at 130 ° C, the mixture is heated for one hour at 125-130 ° C. To the resulting reaction mixture is added dropwise at 120-130 ° C The reaction mixture is then cooled before and after the addition of 50 ml of toluene and the mixture is filtered while hot. The filtrate is cooled with ice until the crystalline substance is separated, which is separated by filtration to obtain 24 starting decanediol
At the same time, the filtrate is concentrated under reduced pressure to obtain an oily product, which is chromatographed on a silica gel column using a mixture of toluene and ethyl acetate (8: 2) as eluent, and 13 g of oily is obtained
10-benzyloxydecan-1-ol. I
Nuclear Magnetic Resonance Spectrum (in CDCl, TMS, ppm): 1.1-2 (16 H, (CHg) q, 3.43 (2H, triplet, -CHjO-); 3.59 (2H, triplet, -CHjOH) ; 4.47 (2H, singlet, -OCHjPh) 7.28 (5H, H of the benzene ring).
176. A mixture of 7 g of 10-benzylcosidecan 1-ol, 8 ml of thionyl chloride and 0.2 MP of dimethylformamide is heated to 1 with 50 ml of α-hexane and after washing the solution with water, it is dried
over anhydrous magnesium sulfate, grow
the solvent is distilled off and the residue is subjected to silica gel column chromatography using toluene as elgoent. 6.7 g of oily 10-benzyloxy-1-chlordecane were obtained, b.p. 135-140 ° C / 0.6-0.9 mm Hg.
NMR spectrum (in spec, TMS, ppm): 1.1-2 16M, (SI ,,) ,; 3.43 (2H, triplet, -SioO-); 3.49 (2H, triplet.
142472910
-CUjCl); 4.47 (2H, singlet -IR, -); 7.28 (5H, H of the benzene ring).
17c. 0.1 ml of methyl iodide and 0.1 ml of methyl iodide are added to a mixture of 1 ml of anhydrous ether and 0.6 g of metallic magnesium.
0
0
five
0
five
0
a crystal of crystalline iodine, after which the mixture is heated to initiate a reaction and then a solution of 6.7 g of 10-benzyloxy 1-chlordecane in 10 ml of anhydrous ether is added dropwise. After completion of the reaction, the reaction mixture is boiled for 2 hours, cooled, and then added dropwise at 0-5 C 5 to a solution of 6 g of 3,4-dibenzyloxybenzaldehyde in 30 ml of tetrahydrofuran. The mixture is stirred at room temperature for 30 minutes and, after adding 300 ml of a 1% aqueous hydrochloric acid solution, extraction is carried out with 100 mp of toluene. The extract is washed with water, dried over anhydrous magnesium sulphate, the solvent is distilled off under reduced pressure. The residue is dissolved in 30 mp of ethanol and left for 1 day at 0-5 C. The precipitated crystals are separated by filtration. After drying the crystals, 5 g of 11-benzyl-hydroxy-1 - (3, 4-benzyl 1-oxyphenyl) undecan-1-ol are obtained, m.p. 50-52 ° C.
Calculated,%: C 80.53; H 8.18.
Found,%: C 80.55; H 7.94.
Reference Example 18 (starting material used in Example 2A).
18a. To a solution of 2.16 g of benzyl alcohol in 30 ml of dimethylformamide was added 1.2 g of sodium hydride in oil (60%). After stirring the mixture for 30 minutes at 20-25 ° C, 10 g of 1,12-dibromododecane was added in one portion at a time, and then stirred for 2 hours at 25-30 ° C. After completion of the reaction, 300 ml of water are added to the reaction mixture and extracted with .m-hexane. The extract is washed with water, dried over anhydrous magnesium sulphate, then the solvent is distilled off. The oily residue was subjected to silica gel column chromatography using n-hexane / ether t9: 1) as eluant, and 3.8 g of 12-benzyloxy-1-bromododecane were obtained as an oily product.
Nuclear Magnetic Resonance Spectrum (in CDCl1, TMS, ppm): 1.2-2 G (20H, - (CHj), o -1; 3.38 (2H, triplet, - CHjBr); 3.44 (2H, triplet, - CHjO-); 4.47 (2I, singlet;); 7.28 (5H, H of the benzene ring).
five
0
P1A24729
18b. According to the method of Reference Example 17c, using the compound obtained in the preceding step 18a, 13-benzyloxy-1- (3,4-dibenzsh1-oxyfennl) tridecan-1-ol, t, mp, 51-53 ° C is obtained.
Calculated,%: C, 80.77; In 8.47.
 50 4
Found%: C 81.01; H 8.74. Reference Example 19A (starting material used in Example 25A). 19a, According to the method of Reference Example 16a, using 1,8-dibromoctane, Po 1 2
stirring and cooling with ice, a solution of 3.06 g of dimethyl ester of 2-oxoctbl phosphonic acid in 10 MP of dimethoxy-ethane. After adding 5 ml of dimethyl sulfoxide to the reaction mixture and stirring for 1 h at room temperature, a solution of 2.22 g of 3,4-diacetoxybenzaldehyde in 10 ml of dimethoxyethane is added dropwise and the mixture is stirred for 3 hours at room temperature. Then add 400 mp of water, extract twice with ether, 50 ml each time, and wash extract 20
8-benzyloxy-1-bromooctane is radiated, vivified with water, dried over anhydrous de oily product.
NMR spectrum (in CDCL, TMS, ppm); 1.1-2.1 (12H, - (CH.,) 3.38 (2H, triplet,); 3.44 tZH, triplet, -CHjO -); 4.47 (2H, singlet,); 7.28 (5H, H of the benzene ring).
196. According to the method of Reference Example 17c, using the compound obtained in Step 19a, 9 benzyloxy-1- (3, .4 benzyloxyfennl) but-25 were prepared. Reference compounds prienan-1-ol were obtained, m.p. 46-48 S.merov 22-24.
Calculated,%: C 80.26; H 7.86. Reference Example 22 (initial weight with magnesium sulfate and concentrated under reduced pressure. The residue is subjected to column chromatography on silica gel (120 g) using a mixture of toluene and ethyl acetate as the solvent and 2.67 g of 1- (3,4-diacetoxyphenyl ) non-1-en-3-one.t., 71-72 ° C.
According to the method of reference example 21
Found,%: C 80.08; H 7.90.
Reference Example 19B (starting material used in Example 25B).
19a. According to the method of Reference Example 17a and 176, using nonanediol, 9-benzyloxy-1-chlorononane, m.p. 128-130 p / 0.6-0.7 mm Hg.
196. According to the method of reference example 17c, using 9-6enzyloxy-1-chlorononane, 10-6enzyloxy-1- (3,4-dibenzyloxyphenyl decac-1-ol, mp = 45-47 ° C) are obtained.
Calculated,%: C, 80.40; H 8.02.
C-) 7H4404
Found,%: C 80.30; H 8.02.
Reference Example 20. (starting material used in Example 26).
. According to the procedure of Reference Example 17c, using 4-6enzyloxy-3-methoxy-6-aldehyde and 10-benzyloxy-1-chlordecane, 11-benzyloxy-1- (4-6-phenyloxy-3-methoxyphenyl) undecan-1-ol is obtained, m.p. 43-45 S.
Calculated,%: C 78.33; H 8.63.
the substance used in example 28).
1- (3,4-Diacetoxyphenyl) -4-met1Ш- 2Q oct-1-en-3-one, oily product.
Nuclear Magnetic Resonance Spectrum (in CDC1 ,, internal TMS standard, ppm): 0.89 (ZN); 1.05-1.9 (9H); 2.8 (6H); 2.75 (1H); 6.6-7.7 (5H).
Reference Example 23 (starting material used in Example 29).
1- (3,4-Diacetoxyphenyl) -4-met1-non-1-en-3-one, oily product.
Nuclear Magnetic Resonance Spectrum (in CDCl1, internal standard TMS, ppm): 0.88 (3N); 1.05-1.9 (11H); 2.3 (6H); 2.77 (1H); 6.66-7.7 (5H).
Reference Example 24 (starting material used in Example 30).
1- (3,4-Diacetoxyphenyl) dec-1-en-3-one, m.p. 66-67 C.
Calculated,%: C 69.34; H 7.56.
40
45
50
Sgo
Found,%: C 69.38; H 7.72.
Reference Example 25 (starting material used in Example 31).
To a solution of 1.27 g of 3,4-dibenzyloxy-sibeisaldehyde in 150 ml of tetrahydrofuran is added dropwise Grignard reagent 55 prepared from 10.4 g of 2-methyl-2- (6-bromhexyl) -1.3 -dioxalan and 1.1 g of magnesium, at a temperature below 5 ° C. After stirring the mixture
С Я Н 410 4
Found,%: C 78.24; H 8.62,
Reference Example 21 (starting material used in Example 27).
To a mixture of 400 g of sodium hydride in oil (60%) and 50 mp of 1,2-dimethoxyethane is added dropwise at
stirring and cooling with ice, a solution of 3.06 g of dimethyl ester of 2-oxooctane-phosphonic acid in 10 MP of dimethoxy-ethane. After adding 5 ml of dimethyl sulfoxide to the reaction mixture and stirring for 1 h at room temperature, a solution of 2.22 g of 3,4-diacetoxybenzaldehyde in 10 ml of dimethoxyethane is added dropwise and the mixture is stirred for 3 hours at room temperature. Then 400 ml of water are added, extracted twice with ether, 50 ml each time, the extract is washed with water, dried over anhydrous
watered with water, dried over anhydrous
magnesium sulfate and concentrate under reduced pressure. The residue was subjected to flash chromatography (120 g) using a mixture of ethyl acetate and toluene as the solvent and 2.67 g of 1- (3,4-diacetoxyphenyl) non-1-en-3-one. square 71-72 ° C.
According to the method of reference example 21
The property used in Example 28).
1- (3,4-Diacetoxyphenyl) -4-met1Ш-кт-1-ene-З-one, oily product.
Nuclear Magnetic Resonance Spectrum (in CDC1 ,, internal TMS standard, ppm): 0.89 (ZN); 1.05-1.9 (9H); 2.8 (6H); 2.75 (1H); 6.6-7.7 (5H).
Reference Example 23 (starting material used in Example 29).
1- (3,4-Diacetoxyphenyl) -4-met1-non-1-en-3-one, oily product.
Nuclear Magnetic Resonance Spectrum (in CDCl1, internal standard TMS, ppm): 0.88 (3N); 1.05-1.9 (11H); 2.3 (6H); 2.77 (1H); 6.66-7.7 (5H).
Reference Example 24 (starting material used in Example 30).
1- (3,4-Diacetoxyphenyl) dec-1-en-3-one, m.p. 66-67 C.
Calculated,%: C 69.34; H 7.56.
Sgo
Found,%: C 69.38; H 7.72.
Reference Example 25 (starting material used in Example 31).
To a solution of 1.27 g of 3,4-dibenzyloxy-sibeisaldehyde in 150 ml of tetrahydrofuran is added dropwise a Grignard reagent prepared from 10.4 g of 2-methyl-2- (6-bromohexyl) -1.3- dioxalan and 1.1 g of magnesium, at a temperature below 5 ° C. After stirring the mixture
2 hours at room temperature with TeNmepaType, water is added to it, acidified with dilute hydrochloric acid and extracted with toluene. The extract is washed with water, dried over anhydrous magnesium sulphate and concentrated under reduced pressure. 300 MP of acetone and 0.1 g of p-toluenesulfonic acid are added to the residue, the mixture is stirred for 1 day at room temperature and concentrated under reduced pressure. The residue is extracted with toluene, the extract is washed with a 5% aqueous solution of sodium hydrogen carbonate, then with water, dried over anhydrous magnesium sulfate and concentrated under reduced pressure to give an oily product.
which is subjected to column chromium
chromatography on silica gel (500 ml) using toluene / ethyl acetate (19: 1) as an eluant, to obtain 4.4 g of 1- (3,4-dibenzsh1oksifesh1l) - nonan-1,8-dione, mp, 64-66 S.
Reference Example 26 (starting material used in Example 32).
A solution of 0.8 g of 1- (3, A-dibenzyl-oxyphenyl) nonan-1,8-dione in 10 ml of tetrahydrofuran is added under ice-cooling to a solution of 0.1 g of lithium aluminum hydride in 50 MP ether after which the mixture was mixed for 2 hours at room temperature. Then 50 mp of toluene is added to the reaction mixture and acidified by the addition of dilute hydrochloric acid. The toluene solution is separated, washed with 5% aqueous sodium bicarbonate solution, then with water, dried over anhydrous magnesium sulphate and concentrated under reduced pressure to obtain 0.8 g of 1 (3,4-di-benzyloxy-phenyl) as an oil non-1,8-diol.
Nuclear Magnetic Resonance Spectrum (in CDCl ,, TMS, ppm): 1.05-1.8 (15H); 3.8-4 (1H); 4.56 (1H) 5.18 (2H); 5.2 (2U; 6.8-6 (13H).
Reference Example 27 (starting material used in Example 33).
27a. According to the procedure of reference 25, using a Grignard reagent prepared from 3 g of 3,5-dibenzyloxyphenylbenzepyde, 2.5 g of 2-methyl- (7-bromoheptyl) -1,3-dioxapane and 0.3 g of magnesium , obtain 0.8 g of 1- (3,4-dibenzyloxyphenyl) decane-1,9-dione, so pl. 72-74 ° C.
276. According to the procedure of ssypnogo example 26, using 1 g of 1- (3,4-dibenzyl
Q g
0
five
P
five
five
0
hydroxyphenyl) decane-1,9-dione as the starting compound, 1 g of 1- (3,4-dibenzyloxyphenyl) decane-1,9-diol is obtained, m.p. 66 ° C.
Calcium Example 28 (starting material used in Example 34).
According to the procedure of Reference Example 25, using 8 g of 3,4-dibenzpoxibenzaldegpd and Grignard reagent prepared from 8 g of 2-ethyl-2- (6-bromohexyl) -, 3-dioxalane and 850 gig magnesium, 2 1- (3,4-dibenzyl-oxy) decane-1,8-dione, - mp. 67-68 C,
Reference Example 29 (starting material used in Example 35).
29a A mixture of 640 mg of sodium hydride in oil (60%) and 10 ml of dimethylsul1 foxid is stirred for 45 min at 75-80 ° C. After cooling the mixture, a solution of 8.2 g of 8-methylenedioxynonyltriphenylphosphonium bromide prepared from 2 -methyl-2- (7-bromoheptum 1) - 1,3-dioxolane triphenylphosphine, in 50 ml of dimethyl sulfoxide. After 10 minutes, a solution of 2.5 g of 3,4-dibenzyloxybenzaldehyde in 10 mp of dimethyl sulfoxide at room temperature is added to the mixture and stirred for 1 day. 500 ml of water are then added to the reaction mixture and the resulting product is extracted with ether. The extract is washed with water, dried over anhydrous magnesium sulphate and concentrated under reduced pressure to give an oily product, which is subjected to silica gel column chromatography (200 ml using hf-hexane and ether (1: 1) as eluant, to give 1, 4 g of 1- (3,4-dibenzyloxyphenyl) -9-ethnlen-dioxide-1-ene.
YL spectrum (in CDC1 ,, TMS, ppm): 1.05-1.8 (11H); 1.9-2.4 (2H); 3.85 (4H); 5.04 (4H); 6-7.5 (15H).
296. A mixture of 1.4 g of 1- (3,4-dibenzsh1- hydroxyphenyl) -9-ethylenedioxide-1-ene, 50 ml of acetone and 50 mg of p -toluenesulfonic acid is stirred for 1 day at room temperature. Then, after adding 50 mg of sodium carbonate, the reaction mixture is concentrated under reduced pressure, after adding 50 mg of sodium carbonate, the reaction mixture is concentrated under reduced pressure and, after adding 50 MP, water is extracted with toluene. The extract is washed with water, dried over anhydrous magnesium sulphate and conc10.
1514247291b
centrifuged under reduced pressure with washed with water, dried over non-obtainment 1.1 g of 1- (3,4-dibenzyloxy-magnesium sulphate and dissolved phenyl) dec-1-en-9-one in the form of oil.
Nuclear Magnetic Resonance Spectrum (in CDC1, TMS, ppm): 1.05-1.8 (8H); 2.1 (3N); 2.1-2.6 (4I); 5.16 (4H); 7-7.6 (15H).
, Reference Example 30 (starting material used in Example 36).
According to the procedure of Reference Example 1a, using 1.2 g of 4-benzipoxy-3-methoxy-sibenzaldehyde and 1.53 g of 2-oxooctylphosphonic acid dimethyl ester, 1.27 g of 1- (4-benzyloxy-3-methoxyphenyl) non- 1-en-3-she, so pl. .78-31 C.
Reference Example 31 (starting material used in Example 37).
31a. 200 mg of sodium hydride in oil (60%) are added to a solution of 1.2 g of 1- (3,4-dihydroxyphenyl) ional-3-one in 10% di-β-mg-formamide and after stirring the mixture for 15 minutes at room temperature temperature is added to it with 0.9 g of benzyl bromide, after which it is extracted with 25 mp of toluene. The extract is stirred for 15 minutes at room temperature, washed with water, and then heated over the precipitate. Then another 200 mg of sodium hydride in oil (60%) are added, the mixture is stirred for 15 minutes at room temperature, 0.9 benzyl bromide is added, and
The body is distilled off under reduced pressure to obtain 1.6 g of 1- (3,4-d11bg n-zyloxyphenyl) -3-methyl-non-1-3-ol.
Nuclear Magnetic Resonance Spectrum (in CDC1 ,, TMS, ppm): 0.88 (3N, -CH,); 1.1-1.9 15H, --CHj-COH (CH,) - (CH,) 5-, l; 1.18 (3N, -CH,); 2.4-2.8 (211,); 5.08 (4H, -OCHjX 2); 6.5-7.6 (13H).
Reference Example 32- (starting material used in Example 38).
A solution of 0.4 g of 3-3,4-dibenzyloxy-5-phenyl propioaldehyde in 5 ml of anhydrous tetrahydrofuran is cooled to 0-5 ° C, after which it is added 5T MP of an ethereal solution of cyclohexyl magnesium bromide prepared and 0.82 g of Oi-.i- my cyclohexyl. Then the reaction mixture is stirred for 13 minutes and after adding 50 ml of a 5% -N () TH aqueous solution of hydrochloric acid to it
. 30 continue stirring for 1.5 hours at
room temperature. After addition of 50 ml of water to the reaction mixture, the product is extracted with toluene. The extract is washed with water, dried over anhydrous magnesium sulphate and the solvent is distilled off under reduced pressure. The residue obtained is subjected to silica gel column chromatography using magnesium sulfate as eluoride, the solvent is distilled off under reduced pressure to give an oily product, which is subjected to silica gel column chromatography using toluene as an eluent and 0.2 g of 3- is obtained. (3,4-Dibenzyloxyphene) -1-cyclohexylpropan-T-ol, m.p. 107-.
Vyisleno,%: C, 80.89; And 7.96.
C 27 1Co O er
Found,%: C 80.88; And 8.15. Example 1. In 20 ml of ethanol, 0.4 g of 1- (3,4-dibenzyloxytoluene) is dissolved to obtain 1.8 g of 1- (3,4-phenyl) -4-methyloct-1-cn-3-ol and pomeite
Dibelyloxyphenyl) nona-3-one in the form of a sticky product.
Nuclear Magnetic Resonance Spectrum (in CDCl1, TMS, ppm): 0.87 (3N, -CH,); 1.05-1.8 8H, - (CH,) 1.3 (2H,); 2.55- 2.85 4H, (0) CH, 5.07 (4H, 2); 6.5-7.5 (13H).
316. A solution of 1.75 g of 1- (3,5-dibenzyloxyphenyl nonan-3-one in 10 ml of tetrahydrofuran is cooled to 0-5 ° C, after which Grignard reagent prepared from 0.24 g of metallic magnesium and 1.7 g of methyl iodide. The mixture is then stirred for 15 minutes and, after adding 50 ml of a 5% aqueous solution of hydrochloric acid, the product is extracted with toluene.
The cell solution is catalytically reduced at room temperature, temperature and atmospheric pressure using 0.1–10% palladium-carbon as
 catalyst until the absorption of hydrogen is stopped. After the completion of the reaction, the catalyst is filtered off and the filtrate is concentrated under reduced pressure to obtain 0.23 g (1-3, - "- dihydroxyphen-1-sh) -4-methyl octal-3-ol.n. Nuclear Magnetic Resonance Spectrum (in CDC1 ,, internal standard, TMS, ppm): 0.7-1.8 (1 5H); 2.57 C2H); 3.45 (1H); 6.4-6.8 (311). PRI mme R 2. According to the method of irims
55 pa 1, using 0,85 g of 1- (3,4-dibenzyloxyphenyl) non-1-ene-3-ol, 0.4 g of 1- (3,4-dihydroxylphenyl 1) nonan-3-ol.
0
washed with water, dried over anhydrous magnesium sulphate and dissolved
-n 25 extracted with 30 mp of toluene. The extract is washed with water;
The body is distilled off under reduced pressure to obtain 1.6 g of 1- (3,4-d11bg n-zyloxyphenyl) -3-methyl-non-1-3-ol.
Nuclear Magnetic Resonance Spectrum (in CDC1 ,, TMS, ppm): 0.88 (3N, -CH,); 1.1-1.9 15H, --CHj-COH (CH,) - (CH,) 5-, l; 1.18 (3N, -CH,); 2.4-2.8 (211,); 5.08 (4H, -OCHjX 2); 6.5-7.6 (13H).
Reference Example 32- (starting material used in Example 38).
A solution of 0.4 g of 3-3,4-dibenzyloxy-5-phenyl propioaldehyde in 5 ml of anhydrous tetrahydrofuran is cooled to 0-5 ° C, after which it is added 5T MP of an ethereal solution of cyclohexyl magnesium bromide prepared and 0.82 g of Oi-.i- my cyclohexyl. Then the reaction mixture is stirred for 13 minutes and after adding 50 ml of a 5% -N () TH aqueous solution of hydrochloric acid to it
extracted with 30 mp toluene. The extract is washed with water;
aqueous magnesium sulfate, the solvent is distilled off under reduced pressure to obtain an oily product, which is subjected to column chromatography on silica gel using toluene as an eluent to obtain 0.2 g of 3- (3,4-dibenzyloxyphenyl) -1-cyclohexylpropane-T- ol, m.p. 107-.
Vyisleno,%: C, 80.89; And 7.96.
C 27 1Co O er
Found,%: C 80.88; And 8.15. Example 1. In 20 ml of ethanol, 0.4 g of a 1- (3,4-dibenzyloxy-chenium solution was dissolved in the catine. Tightly reduced at room temperature, temperature and atmospheric pressure, using 0.1 g of 10% palladium on carbon as
 catalyst until the absorption of hydrogen ceases. After the end of the reaction, the catalyst is filtered off and the catalyst is concentrated under reduced pressure to obtain 0.23 g (1-3, - "- dihydroxyphen-1-sh) -4-methyl octal-3-ol.n. Nuclear Magnetic Resonance Spectrum (in CDC1 ,, internal standard, TMS, ppm): 0.7-1.8 (1 5H); 2.57 C2H); 3.45 (1H); 6.4-6.8 (311). Example 2. According to the method of irims55 pa 1, using 0.85 g of 1- (3,4-dibenzyloxyphenyl) non-1-en-3-ol, 0.4 g of 1- (3, 4-dihydroxyfonish1) nonan-3-ol.
Nuclear Magnetic Resonance Spectrum (in CDCl1, internal standard TMS, rrga): 0.8-1.9 (1H); 2.55 (2H); 3.6 (1H); 6.4-6.8 (ЗН).
Example 3. Using as a catalyst 0.2 g of 10% palladium on carbon, the catalyst is reduced at room temperature and atmospheric pressure until the absorption of hydrogen ceases 0.5 g 1- (3, A-dibenzyloxyphenyl) non-1 -en-3-one in a mixture of 10 MP of methanol and 10 ml of ethyl acetate. Then the catalyst is filtered off and the filtrate is concentrated under reduced pressure. The residue is subjected to column chromatography on silica gel using a mixture of toluene and ethyl acetate (10: 1) as eluent to obtain white crystals of 1- (3,4-dihydroxyphenylnonan-3-one, ZO-3Z C.
C, 71.9; H 8.86.
m.p.
Calculated
С, Н „0, Found,% i
C, 71.66; H 8.77.
Example 4. In a mixture of 30 mp of ethyl acetate and 5 ml of ethanol, 1.5 g of 1- (3,4-dibenzyloxyphenyl) -pentedec-1-en-3 oia H are dissolved. The dissolved compound is catalytically reduced at room temperature and atmospheric pressure using as catalyst, 0.2 g of 10% palladium on carbon until absorption ceases. Then the catalyst is filtered off and the filtrate is concentrated under reduced pressure. The residue was subjected to silica gel column chromatography using toluene / ethyl acetate (10: 1) as an eluant to obtain 0.55 g of 1- (3,4-dihydroxyphenyl) pentadecan-3-one-in the form of white crystals, mp. 67-68 C.
Vyisleno,%: C, 75.41; And 10.24.
one
Found,%: C 75.12; H 10.38.
After the end of the elution of 1- (3,4-dihydroxyphenyl) pentadecan-3-one, the elution is continued using toluene and toluene as an eluent to obtain 0.1 g of 1- (3,4-dihydroxyphenyl) pentadacan-3- ol in the form of white crystals, so pl. 63-64 S.
Calculated,%: C, 74.95; H 10.78.
with „1H, oh,
Found Z: C 74.88; H 10.78. According to the procedure of Example 4, the compounds of Examples 5-8 are prepared.
Example 5 (using the connection ssypnogo example 4).
1- (3,4-Dioxyphenyl) -D-ethyl-3-oktaion), oily product, yield 65%.
Nuclear Magnetic Resonance Spectrum (in SOSTS, TMS internal standard, ppm): 0.6-1.8 (14H); 2.3 (1H); 2.67 (4H); 6.4-6.8 (ЗН). 1- (3,4-Dioxyphenyl) -4-ethyl-3-octanol (b), oily product, yield
Nuclear Magnetic Resonance Spectrum (in CDCl1, internal TMS standard, ppm): 0.85 (6H); 1.1-1.9 (11H); 2.67 (2H); 3.63 (1H); 6.4- 6.7 (ЗН).
Example 6, (use the connection of reference example 5).
1 - (3,4-Dioxyphenyl) -3-hexanone (a), so pl. 37-39 C, yield 60%.
Calculated,%: C 69.21; H 7.74. ibO,
Found,%: C 68.94; H 7.91. 1- (3,4-Dioxyphenyl) -3-hexanol (b), oily product, yield 10%.
Nuclear Magnetic Resonance Spectrum (in CDCl, internal standard TMS, ppm): 0.9 (3N); 1.1-1.9 (6H); 2.6 (2H); 3.75 (1H); 6.6- 6.9 (ЗН).
Example 7 (using the compound of sysypnogo example 6).
1- (3,4-Dioxyphenyl-3-octanol (a), t, pl. 53-55 C, yield 63%.
Calculated,%: C 71.16; H 8.53.
Sd4 NgoO-
Found,%: C, 70.87; H 8.74.
1- (3,4-Dioxyphenyl) -3-octanol, oily product, yield 11%.
Nuclear Magnetic Resonance Spectrum (in CDC1 ,, internal TMS standard, ppm): 0.9 (3N); 1.1-1.9 (UN); 2.6 (2H); 3.65 (1H); 6.5-6.9 (ЗН).
Limer 8 (based on the compound of Reference Example 7).
1- (3,4-Dioxyphenyl) -3-decanone (a), t, pl. 65-6b С, yield 65%.
Calculated,%: C, 72.69; H 9.15.
WITH ,
Found,%: C 72.42; H 9.48.
1- (3,4-Dioxyphenyl) -3-decanol (b), oily product, yield 10%.
Nuclear Magnetic Resonance Spectrum (in CDC1 ,, internal TMS standard, ppm): P, 9 (3N); 1.1-1.9 (14H); 2.6 (2H); 3.65 (1H); 6.5-6.9 (ЗН).
According to the method of example 1, the compounds of examples 9-11 are obtained.
 9142472920
Example 9. 1- (3,4-Dioxyfe-like oily product 0.1, g
nile) -3 shchecanol, so pl. 45-A7 s, you-1- (3, A-dioxmFoyl) -D-dskanol, 89%.
turn 69%.
Calculated,%: C, 72.82j; H, 10.06.
CH HjeO,
Found,%: C 72.76; H 10.29.
Example 10. 1- (3,4- "Dioxif Nile) -3-dodecanol, so pl. 53-55 ° C, yield 80%.
Calculated,%: C 73.43; H 10.27.
C, 8H, SO,
Found,%: C 73.48; H 10.47. Example 11. 1- (3,4-Dioxyphenyl) -4-metsh1-3-nonanol, oil


product yield 85%.
Nuclear Magnetic Resonance Spectrum (in CDC1 ,, internal TMS standard, ppm): 0.7-1.9 (17H); 2.48- (2H); 3.55 (1H); 6.5-6.9 (ЗН).
According to the method of example 3 receive the compound of example 12.
Example 12. 1- (3,4-Dioxyfennl 4-methyl-Z-octanone, oily product, yield 70%.
Nuclear Magnetic Resonance Spectrum (in CDC1 ,, internal TMS standard, ppm): 0.6-1.8 (12H); 2.5 (1H); 2.74 (4H); 6.4-6.8 (ЗН).
Example 13. A solution of 0.5 g of 1- (3,4-dibenzyloxyphenyl) decan-3-ol in 10 ml of ethanol is catalytically hydrogenated using 0.2 g of 10% palladium on




coal at room temperature and atmo-benzyloxyphenyl) -1-cyclohexyl-1 spherical pressure, before termination of the absorbed ethanol, is obtained 0.06 g of 2- (3,4-hydrogen of hydrogen). ethanol,
the catalyst is filtered off, atp.pl. 106-10 ° C, yield 89%. the filtrate is concentrated under reduced Calculated,%: C 71,16; H 8.53. pressure to obtain 0.28 g of 1- (3,4- - dioxyphenyl) -2-decanol in the form of oil CM
Found,%: C, 70.99; H 8.61.
figurative product.
Nuclear Magnetic Resonance Spectrum (in CDCl1, internal standard TMS, ppm): 0.89 (3N, -CH,); 1.1-1.7 (14H, (-SHg)); 1.62 (2H, -CHj-); 3.74 (1H, -CHON-); 6.4-6.9 (ZN, N benzene ring).
Example 14. According to the method of example 13, using 0.3 g of 1- (3,4-dibenzyloxyphenyl) -2-undecanol, receive, in the form of an oily product 140 mg of 1- (3,4-dioxyphenyl) -2-undecanone, yield 96%.
Nuclear Magnetic Resonance Spectrum (in CDClI, internal standard TMS, ppm): 0.86 (3N, -CH,); 1-1.7 (14H, - (CH) y-); 2.47 (2H,); 3.56 (2H, -CHN-); 6.6-6.9 (ZN, N benzene ring).
Example 15. According to the method of example 4, using 0.8 g of 1- (3,4-benzyloxyphenyl) -2-decan-4-one, is obtained in
yield 97%.
turn 69%.
Nuclear Magnetic Resonance Spectrum (p CDC1 ,, internal standard SCM, ppm): 0.86 (3N, -SI,); 1.1-1.8 (14H); 1.48 (2H, -CH, -) i 3.61 (1H, -CHON); 6.4-6.8 (3N, N benzene ring).
Example 16. According to the procedure of Example 13, using 0.5 g of 1- (3,4-benzyl-oxyphenyl) -2-nonanol, -7.7 g of 1- (3,4-dig1-hydroxyphenyl) -2 is obtained as an oily product. -nonanol,
Nuclear Magnetic Resonance Spectrum (in CDCLj), internal standard TMS, rrga): 0.89 (3N, - CH); 1.1-1.7 (12H, - (CH, b); 1.62 (2H, -CHj); 3.75 (1H, -CHOH-); 6.4-6.9 (GH, H benzene rings).
Example 17. According to the procedure of Example 13, using 0.5 g of 1- (3,4-dibenzyloxyphenyl) -2-undecanol, 0.29 g of 1- (3,4-dihydroxyphenyl) -2-undecanol is obtained, 0 is obtained. , 29 g of 1- (3,4-dihydroxyphenyl) -2-undecanol, m.p. 56-58 ° C, yield 95%.
Calculated,%: C, 72.82; H 10.06 ..,
 HjgO, Found,%: C 72.70; H 10.26.
Example 18. According to the method of example 13, using 0.15 g of 2- (3,4-dit. Pl. 106-10 ° C, yield 89%. Calculated,%: C 71.16; H 8.53.
CM
0
five
0
five
Found,%: C, 70.99; H 8.61.
Example 19. According to the method of Example 4, using 0.54 g of 1- (3,4-dibenzyloxyphenyl) -3-decene-5-one, 0.28 g of 1- (3,4-dioxyphenyl) -5-decanone t is obtained. pl. 76-78 ° C, yield 71%.
Calculated,%: C 72.14; H 9.84.
sixteen
Found,%: C 72.18; H 9.75.
Example 20. According to the procedure of Example 13, using 0.3 g of 9- (3,4-dibenzyloxyphenyl) -2-nonanone, in the form of an oily product, 0.16 g of 9- (3,4-dioxyphenyl) -2-nonano- on, yield 95%.
Nuclear Magnetic Resonance Spectrum (in CDC1 ,, internal TMS standard, ppb): 1-1.8 (YUN); 2.16 (3N); 2.3-2.6 (4H); 6.5-6.9 (ЗН).
Example 21. To a solution of 150 mg of 1- (3,4-dihydroxyphensh1) decan-5-one in 1.5 ml is added while cooling
211A24729. . 22
ice 20 mg of sodium ohydride, after According to the method of example 23 get what the mixture is stirred for 30 minutes Behind- . compounds of examples 24 and 24a, B, the solvent was distilled off from the reaction mixture, and after adding to the resulting residue 10 ml of water, it was extracted with ether. The extract is dried over anhydrous magnesium sulphate and, after distilling off the solvent, white crystals of 1- (3,4-dig1 vdroc. Syphenyl) decan-5-ol are obtained, which after Example 24 (based on the compound of Reference Example 186) are added.
13- (3,4-Dioxyphenyl) -1-tridecano m.p. 93-95 ° C, yield 81%.
Calculated,%: C 73.98; H 10.46.
C, 9.H-} i -
Found,%: C 73.73; H 10.75.
Example 25A (based on the compound of Reference Example 19A, one hundred di b).
Neither N-hexane is filtered off. Yield 117 mg.
Calculated,%: C 72.14; H 9.84.
Found,%: C 72.18; H 9.75.
Example 22. Using 0.1 g of 10% palladium on carbon as a catalyst, 560 mg of 1-3,4-dibeisyl-oxyphenyl-3-methoxy-4-methyl octo-1-ene are catalytically reduced to a mixture of 5 ml methanol and 3 ml of ethyl acetate at room temperature and atmospheric pressure until the absorption of hydrogen ceases. The catalyst is then filtered off and the filtrate is concentrated under reduced pressure to obtain 330 mg of oily 1- (3,4-dihydroxyphenyl) -3-methoxy-4-methyloctane.
Nuclear Magnetic Resonance Spectrum (in CDC1 ,, internal TMS standard, ppm): 0.7-1.9 (5H); 2.52 (2H5; 3.05 (1H); 3.4 (ZN); 6.5-6.9 (ZN).
Example 23. In 40 ml of acetic acid, 4.4 g of 11-benzyloxy-1- (3,4-dibenz1-oxyfenyl) undecan-1-ol are dissolved and the dissolved compound is catalytically reduced in the presence of 1 g of 10% - palladium on coal at room temperature and atmospheric pressure until the absorption of hydrogen ceases. After completion of the reaction, the catalyst is filtered off and after 300 ml of water is added to the filtrate, the product is extracted twice with ethyl acetate. Each time 70 ml. The extract is washed with water, dried over anhydrous magnesium sulphate, after which the solvent is distilled off to obtain a solid, which is recrystallized from a mixture of step-acetate with toluene (1: 1) to obtain 1.5 g of 11- (3,4-dihydroxyphenyl) unde- Can-1-ol, so pl. 92-93 C.
Calculated,%: C, 72.82; H 10.06.
With IT
Found,%: C 73.06; H 10.29.
According to the procedure of Example 23, the compounds of Examples 24 and 24A, B, are prepared.
Example 24 (based on the compound of Reference Example 186).
13- (3,4-Dioxyphenyl) -1-tridecanol, m.p. 93-95 ° C, yield 81%.
Calculated,%: C 73.98; H 10.46.
C, 9.H-} i -
Found,%: C 73.73; H 10.75.
Example 25A (based on the compound of Reference Example 19A, step b).
9- (3,4-Dioxyphenyl) -1-nonanol, mp. 89-91 ° C, yield 73%.
Calculated,%: C, 71.39; H 9.59.
C ,, N ,, 0,
Found,%: C 71,12; H 9.80.
Example 25B, (based on the compound of Reference Example 19B, step b).
10- (3,4-Dioxyphenyl) -1-decanol, mp. 89-91 ° C, yield 70%.
Calculated,%: C 72.14; H 9.84.
five
0
five
0
five
0
With eH2b 5c
Found,%: C 71.96; H 10.11.
Example 26, (based on the compound of Reference Example 20).
According to the method of Example 23, 11- (4-hydroxy-3-methoxyphenyl) -1-undeca-iol, m.p. 72-74 s, yield 90%.
Calculated,%: C 73.33; H 10.72.
WITH,
Found,%: C 73.09; H 10.26.
Example 27. In 10 ml of methanol, 830 mg of 1- (3,4-diacetoxyphenyl) non-1-ene-3-one is dissolved and after adding to the solution 7.5 ml of aqueous 1 and. The sodium hydroxide solution is stirred at room temperature for 30 minutes. The reaction mixture is then cooled with ice and, after adding 25 ml of water, acidified with aqueous 1N. with a solution of hydrochloric acid to form crystals, which are separated by filtration, washed with water to obtain 580 mg of 1- (3,4-dihydroxyphenyl) non-1-en-3-one, m.p. 114-115 ° C.
Calculated,%: C, 72.55; H 8.12.
With isHjoO,
Found,%: C 72,32; H 8.23. Example 28. An aqueous solution acidified with hydrochloric acid and prepared as described in Example 27, but using 1 g of 1- (3,4-diacetoxyphenyl) 4-methyloct-1-el-3-one, is extracted twice with ether each time. on 20 ml. The extract is washed with water, dried over anhydrous magnesium sulphate.
23
under reduced pressure Concentrate
Research institutes with obtaining oily 1 (3,4-dihydroxyphenyl) -4-methyloct-1-e3-it, yield 0.7 g
Nuclear Magnetic Resonance Spectrum (in CDCl ,, internal standard TMS, ppm): 0.88 (3N); 1.05-1.9 (9H); 2.85 (1H); 6.59-7.7 (5H).
Example 29. According to the method of Example 28, using 1 g of 1- (3,4-diacetoxyphenyl) -4-methylnon-1-en-3-one, 0.7 g of oily 1- (3,4-dihydroxyphenyl ) -4-methylnon-1-en-3-one
Nuclear Magnetic Resonance Spectrum (n CDCl1, internal TMS standard, rrga): 0.88 (3N); 1.05-1.9 (11H); 2.84 (GN); 6.59-7.7 (5H).
Example 30. According to the procedure of Example 27, using 0.25 g of 1- (3,4-di-acetoxyphenyl) -1-decen-3-one, O is obtained, 14 g (- (3,4-dioxyphenyl-1-de - price-3-she, mp. 11b-118 with.
Calculated,%: C 73.25; H 8.45.
CifeH zO,
Found,%: C 73.30; H 8.71.
Example 31. Using 0.5 g of 10% palladium on carbon, catalytically reduce 3.2 g of 1- (3,4-dibenzylox phenyl-1,8-nonanediol in 50 ml of ethanol and 1, at room temperature and atmospheric pressure). 5 ml of 5% aqueous perchloric acid until the absorption of hydrogen ceases. After completion of the reaction, the catalyst is filtered off and the filtrate is concentrated under reduced pressure. The residue is subjected to silica gel column chromatography (50 ml) using toluene / ethyl acetate (4: 1) as eluent. The crystals obtained are recrystallized. t from a mixture of toluene with N-hexane to obtain 1- (3,4-dioxyphenyl) -8-nanol, so pl. 73-75 C, yield 1.1 g
Calculated,%: C, 71.97; H 8.86.
C, 5 O 3
Found,%: C 71.91; H 9.12.
Example 32. According to the procedure of Example 31, using 780 mg of 1- (3,4-dibenzyloxyphenyl) -1,8-nonanediol, 210 mg of 1- (3,4-dioxyphenyl) -8-nonanol with m.p. 58-61 S.
Nuclear Magnetic Resonance Spectrum (at CBCI3, TMS, ppm): 1-1.8 (15H); 2.48 (2H); 3.84 (1H); 6.5-6.9 (ЗН).
Example 33. According to the procedure of Example 31, using 1 g of 1- (3,4-dibenz shloxyphenyl) -1, 9-decanediol, 340 mg of 1- (3,4-dioxyphenyl) -9-decanol are obtained, m.p. 43-4b C.








0
2 L
NMR spectrum (in CDC1 ,, TOC, rrga) :. 1.05-1.8 (17H); 2.5 (2I); 3.86 (1H); 6.5-6.9 (311).
Example 3. According to the procedure of Example 31, using 2 g of 1- (3,4-dibeisyloxyphenyl) decane-1,8-diol, 200 mg of 1- (3,4-dihydroxyphenyl) -decan-8-one are obtained with t .pl. 76-78 ° C.
Nuclear Magnetic Resonance Spectrum (in CDS, TMS, ppm): 1.04 (ZN); 1-1.8 (UN); 2.2-2.6 (6H); 6.5-6.9 (ЗН).
Example 35. Pe to the procedure of Example 1, using 1.02 1- (3,4-dibenzyloxy-phenyl) dec-1-en-9-one as the starting 5 product, 450 mg of 1- (3.4) -dig1-shiroxyphenyl) decane-9a with so pl. 74-76 ° C.
Nuclear Magnetic Resonance Spectrum (in CDC1}, TMS, rrga): 0 1.05-1.8 (12H); 2.1 (3N); 2.3-2.52 (4H); 6.5-6.8 (ЗН).
Example 36. According to the procedure of Example 4, using 1.2 g of 1- (4-benzyloxy-5 3 methoxyphenyl) non-1-en-3-one as the starting compound, 660 ml of 1- (4-g1 hydroxy-3-methoxy) are obtained. -) nonan-3-one (a) as an oil and 120 mg of oily 1- (4-hydroxy-3methoxyphenyl) nonan-3-ol (b).
NMR spectrum of the compound a (in AHSC, TMS, ppm): 0.9 (3N); 1-1.8 (811); 2.4 (2H); 2.5-3 (AH); 3,88- (ЗН); 6.5-7 (3N).
NMR spectrum of compound b (in CDCl, TMS, ppc): 0.9 (3N); 1-2 (12H); 2.5-2.8 (2H); 3.4-3.8 (1H); 3,88 (ЗН); 6.6-7 (ЗН).
Example 37. According to the procedure of Example 1, using 1.4 g of 1- (3,4-dibenzyloxyphenyl) -3-methylnsnan-3-ol, 0.7 g of 1- (3,4-digtsroxyphenyl) -3 methylnonane are obtained. Z-ola, mp. 81-83 S. “
Calculated,%: C 72.14; H 9.84.
0
five
0
C 16,
Found,%: C 71.96; H 10.06.
Example 38 To a solution of 0.5 g of 1- (3,4-dihydroxyphenyl) -4-methyloctan-3-ol (see Example 1) in 20 ml of acetic acid is added dropwise a solution of 0.37 g of bromine in 2 ml of acetic acid and after the bromine color disappears, the solvent is distilled off under reduced pressure. The resulting residue is extracted with ethyl acetate. The extract is washed with water, dried over anhydrous magnesium sulphate and the solvent is distilled off under reduced pressure to give a residue, which is subjected to a silica gel column chromatography.
kagel using toluene and ethnyl acetate (2: 1) as that mixture and obtain 0.5 g of 1- (2-bromo-3,4-hydroxyphenyl) -4-methyloctan-3-ol, mp. 68-7GS.
Calculated,%: C 54.39; H 7.00; At 24.12.
C, 5Hj, BrO,
C 34.12; H 7.12;
Found,% B 24.40.
Example 39. According to the procedure of Example 1, using 3- (3,4-dibenzyloxyphenyl) -1-cyclohexylpropan-1-ol 0.2 g, 3- (3,4-dihydroxyphenyl) -1-cyclohexylpropane 1-ol, m.p. 118-119 ° C.
Calculated,%: C, 71.97; H 8.86.
("
Found, Z: C, 71.85; H 8.95. Example 40. Tablets, mg: 11- (3,4-Dihydroxyphenyl) - undecan-1-ol (hereinafter referred to as ALT-116) .50
Lactose113
Grain starch28
Hydroxypropylcellulose 4 Calcium carboxymethyl cellulose4.
Magnesium Stearate 1
Total200
After reaction mixing 50 g of ALT-188, -13 g of lactose and 28 g of starch, 40 ml of a 10% (May / vol) aqueous solution of hydroxypropylcellulose is added to the mixture and the resulting mixture is granulated by wet granulation. The resulting granules are mixed with A g of calcium carboxymethyl cellulose and 1 g of magnesium stearate, after which the mixture is pressed into tablets (200 mg per tablet).
Example 41. Capsules mg:
50
ten
15
20
25
ALT-118
Crystalline cellulose 20 Crystalline lactose 129 Magnesium stearate 1 A total of 200 The indicated components (each in a 1000-fold amount from the specified amount) are mixed and the gelatin capsules are filled with a mixture (200 mg each capsule).
Example 42, Ingal Qi. After dissolving 0.1 g of ALT-118 in approximately 90 ml of a mixture containing ethanol, propylene glycol and purified
1424729 26
diluted with water (in a ratio by weight of 30:10:: 60), the volume of the solution is brought to 100 ml by adding this mixture, after which the resulting mixture is filled in the appropriate containers (10 ml each), which are sealed for use as inhalations.
The compounds of the present invention actively suppress the formation and absorption of MDV-A (slow-acting substances that anaphylaxis), these compounds are used for the prevention and treatment of various allergic diseases, such as bronchial asthma, allergic rhinitis, urticaria, etc., as well as ischemic heart diseases and inflammatory processes caused by MDV-A.
Pharmacological testing. A. Passive peritoneal anaphylaxis (PBA) in rats.
The method used is based on the fact that male rats are weighted. 275-325 g (Shizudka Exp. Animal Agric, Coop Assoe) are sensitized by intraperitoneal (i.v.) injection of 5 ml of diluted (40 times) anti-30 DNF (2,4-dinitrophenyl) reactive serum (PCA titer is passive cutaneous anaphylaxis -1280). After 4 h, 5 ml of Tyrode's solution containing 250 g of heparin and 2 mg of DNP-albumin of bovine serum are injected (ip). The test drug (100 g / kg) was administered by injection of i / b 30 seconds before the angigan was injected in the solution with 0.6 ml of salt. After 5 minutes, the rats were decapitated and int. The peritoneal fluid is collected in polycarbonate tubes on ice by dissection of the abdominal cavity. The substance floating on the surface is separated for biological tests from the cell residue by centrifuging for 5 minutes at 2000 rpm and 4 ° C.
Tests on histamine and MDV-A were carried out on an isolated ileum (the peripheral part of the small intestine, ending in the rectum) of the guinea pigs in the presence of -55712 (sodium (4-acetyl-3-hydroxy-2-propylphenoxy)) -hydroxypropoxyZ-4- - oxo-8-propyl-4H-1-benzopyran-2-car35
45
50
55
bauxyl), and 10 M mepyramine corresponding to TL
atropine.
In this test, 1 unit. MDV-B corresponds to the concentration required to cause a reduction in ileum mors. Testing for histamine and MDV-A is carried out on an isolated ileum (the peripheral part of the small intestine ending in the rectum) of guinea pigs in the presence of -55712 (sodium (4-acetyl -3-hydroxy-2-propylphenoxy) -2-hydroxypropoxyZ-4-oxo-8-propyl-4H-1-benzopyran-2-carp-6
five
bauxyl), and 10 M mepyramine corresponding to GL - T
atropine.
In this test, 1 unit. MDV-B corresponds to the concentration required to cause a reduction in ileum morse20
A variety of actions are proposed with ig known carriers, filler compounds and DNCH.
B, Tests on S-lipogenase and cyclooxygenase.
This method is based on testing for the activity against S-lipogenase, the fraction of cell enzymes of mastitis P-815 (10 cells / ml) is incubated with 0.2 uCi (1-c) aridine acid (56.9 Ci / mol), 0.8 mM CaCl2, 2x10 M indomethacin and test drugs in various concentrations at 37 ° C for 5 minutes. In the case of a cyclooxygenase activity test, CaCl and indomethacin are excluded from the incubated mixture and the incubation is carried out at 37 ° C for 7 minutes. After extracting the product with 8 volumes of ethyl acetate, the extract is concentrated and applied to a TLC plate. For
25
thirty
mi etc. The dosage of these compounds depends on the subject of treatment, the route of administration, the state of the disease, in particular, 0.1-500 mg per day is administered to an adult, or orally or parenterally two or three times a day.

权利要求:
Claims (1)
[1]
Invention Formula
The method of obtaining caecine derivatives of the general formula
HE
he II
35
X-y-z
where X is a normal alkylene of 1-11 carbon atoms or a vinylene group; carbonyl or radical (OR,) R2, where R and R, which are the same or different, are hydrogen or a lower alkyl;
Separating GETA and prostaglandins was carried out by thin layer chromatography in the following solvent system: petroleum ether - diethyl ether - acetic acid (50: 50: 1) and ethyl acetate-2,2,4-trimethylpentane - acetic acid - water (11: 5: 2:10 upper phase) respectively. The radioactive spots are determined by autoradiography, scraped off and the radioactivity counted using a liquid scintillation spectrometer. The activity of 5-lipogenase and cyclooxy-. genases are expressed as the sum of radioactivity of 5-GETE and 5,12-di-GETE, as well as prostaglapdin D,) PGD, PGEi and PGEj, respectively. Values of 1C 50 are calculated by the Probit method.
The proposed compounds, depending on the dosage in the range of 0.01 10 | PM, suppress the formation of 5-lipogenase products and the values of 1C 50 for them are given in Table. 2 and 3. At a concentration of 10 (UM, these compounds are weak in
with known carriers, filler -
mi etc. The dosage of these compounds depends on the subject of treatment, the route of administration, the state of the disease, in particular, 0.1-500 mg per day is administered to an adult, or orally or parenterally two or three times a day.
Invention Formula
The method of obtaining caecine derivatives of the general formula
HE
he II
Y
X-y-z
where X is a normal alkylene of 1-11 carbon atoms or a vinylene group; carbonyl or radical (OR,) R2, where R and R, which are the same or different, are hydrogen or a lower alkyl;
hydrogen, normal or iso-alkyl alkyl containing 1-12 carbon atoms, the sum of carbon atoms in radicals X and Y being at least 3;
characterized in that
compound of general formula
 OR,
Z
X-Y, -Z,
R is benzyl;
X, -alkylene of normal structure, containing 1-11 carbon monoxide, alkenylene of the formula or a radical of the formula
-CO-CCHz); carbonyl "CH-OH or liCH-O. Ni is an alkyn group; has the indicated meanings;
moreover, the sum of carbon atoms
X and
Z is at least equal to reduction using palladium-carbon catalyst, possibly in the presence of perchloric acid.
Priority featured
13.05.83 with X - C-alkylene, Y carbonyl or -CH-; Z - alkylion
sn snoon
(caffeic acid)
18
CH2CH2CHCHN (CH2) zSNz OH CHz
28
СН2СН2СН (СН2) 5СНз ОН
27
CH2CH2C (CH2) 5CH3 O
on the group of normal or isostroy C, X Z 5; R, is benzyl X, is an alkenylene group Y, is carbonyl CH-OH.
10.25.83 at X - C ,, - Cj-n-alkylene;
YSI
(
 lower alkyl; X + X, - C, -Cd-and-alkylene; Y, - -CH
O - lower. Alkyl;
29.12.83 when X - C, -C „-n-alkylene; Z is hydrogen; X, --CO- (CH,) jj
02.24.84 when X is vinylene: Z is C, -Cj-M- or iso-alkyl; Z + Y 3; X | - C, -C ,, -i-alkylene.
Table 1
23.5
13.8
37,8
76.6
5.2
57.3
22,6
55.9
ALT-NO
Example
Drug of formula
HE
70
CH2CH2CH (CH2) 7CH5 OH
69 11
HE
CH2 CH2 CHI SI 1CH2) 4 CH3
82U
SNGS (CH2) 8CHN
about
he
5215
CH2CH2CH2CH (CH2) 5CH3 OH
ALT N6
Example
Drug of formula
he
181
CH2CH2CHN CH (CH2) zSNz it CHZ
PBA rats (100 mg / b) Suppression (%)
Histamine
MDV-A
HE
21.6
53.6
17.6
66.6
 CHI SI 1
OHCHi
he
32.7
58.9
18.4
46.2
table 2
1C 50, M
5-lipogenase
Cyclooxygenase
0.30 Enhanced
Alt no
Example
Drug of formula
70
he
СН2СН2СН (СН2) 7СНз ОН
103 20
(СН2) 7ССНз
about
118 23
(СН2) „ОН
Alt no
Example
Drug of formula
10320
(СН2) 7ССНз О
11823
1C 50, M
5-lipogenase cyclooxygenase
0.10 10
he
0,
he
0,
Table 3
PBA of rats (100 mg / kg (ip), inhibition (X)
Histamine
T
NDV-A
he
17.9
62,8
HE
10.7
69,6
(CH2)
117 25-a
77 29
 CHlCH2) / fCH3 OSS
8.3
43.9
32.4
38.2

类似技术:

---

公开号 | 公开日 | 专利标题

---

SU1424729A3|1988-09-15|Method of producing catechine derivatives

---

CA2105655A1|1992-09-09|Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors

---

PL99931B1|1978-08-31|METHOD OF MAKING NEW PROSTAGLANDIN ANALOGS

---

US4036857A|1977-07-19|Benzopyrans having an unsaturated side chain

---

US3897519A|1975-07-29|Secondary phosphoric acid esters

---

US3781306A|1973-12-25|Bicyclic lactone diformate

---

US4235913A|1980-11-25|9-Hydroxyhexahydrodibeno[b,d]pyrans, 1-substituted-9-hydroxyhexahydrodibenzo]b,d]pyrans

---

US3562336A|1971-02-09|Synthesis of naphthalene derivatives

---

US3932463A|1976-01-13|11-Deoxy-13-dihydro-prostaglandin-9-ketals

---

US4102888A|1978-07-25|3-Thiazolidinyl heptanoic acids

---

US3991187A|1976-11-09|Medicinal compositions and methods of use involving phosphoric acid esters

---

US4057641A|1977-11-08|Method of treating inflammation with 2-|propionic acid

---

CA1258863A|1989-08-29|Cyclohexane derivatives

---

DK142455B|1980-11-03|METHOD OF ANALOGUE FOR THE PREPARATION OF THIAPROSTAGLANDINES

---

US3524867A|1970-08-18|Process for producing cyclopenta |pyrans

---

US3835179A|1974-09-10|Novel 15-substituted prostanoic acids and esters

---

PL105799B1|1979-10-31|METHOD OF MAKING NEW DERIVATIVES / ALPHA-AMINOACETYL / BENZENE

---

US4074063A|1978-02-14|Bicycloalkyl derivatives of prostaglandins

---

US4229585A|1980-10-21|Fluoro-prostaglandins

---

EP0066475B1|1986-10-01|Pharmaceutical composition for use in inducing cytoprotection

---

SU1072801A3|1984-02-07|Process of preparing derivatives of prostacycline or their epimers

---

CA1326675C|1994-02-01|Trienic derivatives with a chromenic structure, their processes of preparation and pharmaceutical compositions containing them

---

US4296121A|1981-10-20|Novel prostaglandin derivatives of the Δ2-PGF2 and Δ2-PGE2 series and process for their manufacture

---

US4086362A|1978-04-25|Prostenoic acid derivatives

---

KR830001919B1|1983-09-23|Method for preparing oron derivatives

同族专利:

---

公开号 | 公开日

---

ES532455A0|1985-06-16|

---

EP0125919A3|1987-01-21|

---

PH19356A|1986-04-02|

---

EP0125919A2|1984-11-21|

---

ES8505914A1|1985-06-16|

---

US4618627A|1986-10-21|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

US1306710A|1919-06-17|Hiroshi nomtjra |

---

NL279980A|1961-06-21|

---

US3471573A|1965-10-04|1969-10-07|Giancarlo Bramanti|Choleretic nuclear-substituted phenylalkyl carbinols|

---

FR2201280B1|1972-10-02|1976-11-19|Bush Boake Allen Ltd|

---

GB1479297A|1974-07-04|1977-07-13|Beecham Group Ltd|4-substituted butan-2-ones but-3-en-2-ones butan-2-ols and but-3-en-2-ols and pharmaceutical compositions containing them|IT1196002B|1984-01-20|1988-11-10|Brichima Spa|PROCEDURE FOR THE SYNTHESIS OF O-ISOPROPOSSIPHENOL|

---

EP0464859A1|1984-05-23|1992-01-08|Green Cross Corporation|A lipoxygenase inhibitor|

---

DE3518655A1|1985-05-24|1986-11-27|Grünenthal GmbH, 5190 Stolberg|NEW PHENOL DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THEM AND METHOD FOR PRODUCING THESE COMPOUNDS AND MEDICINAL PRODUCTS|

---

US4696676A|1986-06-27|1987-09-29|International Flavors & Fragrances Inc.|Use of 1-nonen-3-ol for repelling insects|

---

GR871701B|1986-11-07|1988-03-04|Oreal|Method for preparing 5,6 - dihydrixyindol, and its 3 - alkylated derivative and intermediates|

---

US5283352A|1986-11-28|1994-02-01|Orion-Yhtyma Oy|Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same|

---

US5489614A|1987-11-27|1996-02-06|Orion-Yhtyma Oy|Catechol derivatives, their physiologically acceptable salts, esters and use|

---

YU213587A|1986-11-28|1989-06-30|Orion Yhtymae Oy|Process for obtaining new pharmacologic active cateholic derivatives|

---

FI864875A0|1986-11-28|1986-11-28|Orion Yhtymae Oy|NYA FARMAKOLOGISKT AKTIVA FOERENINGAR, DESSA INNEHAOLLANDE KOMPOSITIONER SAMT FOERFARANDE OCH MELLANPRODUKTER FOER ANVAENDNING VID FRAMSTAELLNING AV DESSA.|

---

WO1989003375A1|1987-10-16|1989-04-20|Terumo Kabushiki Kaisha|Isoprenoid derivatives and pharmaceutical preparation containing same|

---

MTP1031B|1987-12-24|1990-10-04|Orion Yhtymae Oy|New use of cathecol-o-methyl transferaseinhibitors and their physiologically acceptable salts and esters|

---

DE68915750T2|1988-03-02|1994-11-10|Terumo Corp|CATHECHOL COMPOUNDS, METHOD FOR THE PRODUCTION AND PREPARATION OF MEDICINAL PRODUCTS CONTAINING THEM.|

---

GB9004348D0|1990-02-27|1990-04-25|Orion Yhtymae Oy|New use of catechol derivatives and their physiologically acceptable salts and esters|

---

DE4120698A1|1991-06-22|1992-12-24|Gruenenthal Gmbh|New phenoxy-alkanol derivs. which are 5-lipoxygenase inhibitors - used to treat asthma, thrombosis, shock, ischaemic coronary infarction, etc.|

---

DE602006018182D1|2005-08-23|2010-12-23|Kaneka Corp|PROCESS FOR THE PREPARATION OF ARALKYLOXYPYRROLIDINE DERIVATIVES|

---

CN106928030A|2010-07-15|2017-07-07|广州南沙龙沙有限公司|The method that hydroxytyrosol is prepared using organo-metallic compound|

---

US20120130129A1|2010-11-16|2012-05-24|Baylor University|Efficient Method for Preparing Functionalized Benzosuberenes|

---

WO2012131177A1|2011-03-31|2012-10-04|L'oreal|Use of hydroxylated derivatives of vanillin as preserving agent, preservation process, compounds and composition|

---

CN102952066B|2011-08-30|2014-06-04|南开大学|Synthesis and biological activity of cyanoacrylate compound containing pyridylmethyl phenyl ether structure|

---

EP3904327A4|2020-04-30|2021-11-03|Roehm Gmbh|Method for the preparation of hydroxyalkyl- acrylic acid esters by oxidative cleavage of methacrolein acetals|

法律状态:

优先权:

---

申请号 | 申请日 | 专利标题

---

JP58083748A|JPS59225136A|1983-05-13|1983-05-13|1--3-hydroxyalkane and its preparation|

---

JP58199854A|JPS6092230A|1983-10-25|1983-10-25|1-alkane|

---

JP58248034A|JPS60142935A|1983-12-29|1983-12-29|Omega--omega'-hydroxyalkane|

---

JP59034979A|JPH0437812B2|1984-02-24|1984-02-24|

---